Author:
Pei Zengyang,Zhou Degang,Yan Jie,Wang Shenghao,Yang Xu,Pei Zengju
Funder
Specialized Research Fund for the Doctoral Program of Higher Education of China
National Natural Science Foundation of China
Subject
General Pharmacology, Toxicology and Pharmaceutics,General Biochemistry, Genetics and Molecular Biology,General Medicine
Reference31 articles.
1. Drug treatment of type 2 diabetes;Tielmans;Presse Med.,2007
2. Incretin mimetics and DPP-IV inhibitors for the treatment of type 2 diabetes;Nielsen;J. Am. Board Fam. Med.,2005
3. Druce MR, Minnion JS, Field BCT, Patel SR, Shillito JC, Tilby M, et al. Investigation of structure-activity relationships of oxyntomodulin (Oxm) using Oxm analogs. Endocrinology. 2009;150(4):1712–21. doi: https://doi.org/10.1210/en.2008-0828. PubMed PMID: WOS:000264442900020.
4. Oxyntomodulin;Druce;Treat. Endocrinol.,2006
5. Effect of oxyntomodulin, glucagon, GLP-1 and combined glucagon + GLP-1 infusion on food intake, appetite and resting energy expenditure;Bagger;J. Clin. Endocrinol. Metab.,2015
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献